Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Molecular & Cellular Oncology
|
September 19, 2019
All over the place: deciphering HRAS signaling from different subcellular compartments
Walter Kolch, David Matallanas
Current Opinion in Molecular Therapeutics
|
December 15, 2010
New druggable targets in the Ras pathway?
David Matallanas, Piero Crespo
Methods in Molecular Biology (Clifton, N.J.)
|
December 20, 2018
Quantifying the Kinase Activities of MST1/2
Niamh A O'Driscoll, David Matallanas
Biochemical Society Transactions
|
December 3, 2016
The spatiotemporal regulation of RAS signalling
Ana Herrero, David Matallanas, Walter Kolch
Biomolecules
|
February 10, 2021
The Ins and Outs of RAS Effector Complexes
Christina Kiel, David Matallanas, Walter Kolch
Genes
|
June 21, 2016
The MST/Hippo Pathway and Cell Death: A Non-Canonical Affair
Emma Fallahi, Niamh A O'Driscoll, David Matallanas
Cancer Research
|
July 5, 2005
Mammalian sterile 20-like kinases in tumor suppression: an emerging pathway
Eric E O'Neill, David Matallanas, Walter Kolch
Cancers
|
January 23, 2020
RASSF1A Tumour Suppressor: Target the Network for Effective Cancer Therapy
Lucía García-Gutiérrez, Stephanie McKenna, Walter Kolch, et al.
Scientific Reports
|
February 9, 2021
BAX and SMAC regulate bistable properties of the apoptotic caspase system
Stephanie McKenna, Lucía García-Gutiérrez, David Matallanas, et al.
Proteomics
|
October 11, 2008
Proteomics and phosphoproteomics for the mapping of cellular signalling networks
Christian Preisinger, Alex von Kriegsheim, David Matallanas, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Molecular & Cellular Oncology
|
September 19, 2019
All over the place: deciphering HRAS signaling from different subcellular compartments
Walter Kolch, David Matallanas
Current Opinion in Molecular Therapeutics
|
December 15, 2010
New druggable targets in the Ras pathway?
David Matallanas, Piero Crespo
Methods in Molecular Biology (Clifton, N.J.)
|
December 20, 2018
Quantifying the Kinase Activities of MST1/2
Niamh A O'Driscoll, David Matallanas
Biochemical Society Transactions
|
December 3, 2016
The spatiotemporal regulation of RAS signalling
Ana Herrero, David Matallanas, Walter Kolch
Biomolecules
|
February 10, 2021
The Ins and Outs of RAS Effector Complexes
Christina Kiel, David Matallanas, Walter Kolch
Genes
|
June 21, 2016
The MST/Hippo Pathway and Cell Death: A Non-Canonical Affair
Emma Fallahi, Niamh A O'Driscoll, David Matallanas
Cancer Research
|
July 5, 2005
Mammalian sterile 20-like kinases in tumor suppression: an emerging pathway
Eric E O'Neill, David Matallanas, Walter Kolch
Cancers
|
January 23, 2020
RASSF1A Tumour Suppressor: Target the Network for Effective Cancer Therapy
Lucía García-Gutiérrez, Stephanie McKenna, Walter Kolch, et al.
Scientific Reports
|
February 9, 2021
BAX and SMAC regulate bistable properties of the apoptotic caspase system
Stephanie McKenna, Lucía García-Gutiérrez, David Matallanas, et al.
Proteomics
|
October 11, 2008
Proteomics and phosphoproteomics for the mapping of cellular signalling networks
Christian Preisinger, Alex von Kriegsheim, David Matallanas, et al.
Page
of 8